These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32194200)

  • 1. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
    Rubio-Rivas M; Corbella X; Guillén-Del-Castillo A; Tolosa Vilella C; Colunga Argüelles D; Argibay A; Vargas Hitos JA; Todolí Parra JA; González-Echávarri C; Ortego-Centeno N; Trapiella Martínez L; Rodríguez Carballeira M; Marín Ballvé A; Pla Salas X; Perales Fraile I; Chamorro AJ; Madroñero Vuelta AB; Freire M; Ruiz Muñoz M; González García A; Pons Martín Del Campo I; Sánchez García ME; Bernal Bello D; Espinosa G; García Hernández FJ; Sáez Comet L; Ríos Blanco JJ; Fernández de la Puebla Giménez RÁ; Sánchez Trigo S; Fonollosa Pla V; Simeón Aznar CP;
    Autoimmun Rev; 2020 May; 19(5):102507. PubMed ID: 32194200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
    Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP;
    Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.
    Rubio-Rivas M; Corbella X; Pestaña-Fernández M; Tolosa-Vilella C; Guillen-Del Castillo A; Colunga-Argüelles D; Trapiella-Martínez L; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Segovia-Alonso P; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñoz M; Fonollosa-Pla V; Simeón-Aznar CP; ; Callejas Moraga E; Calvo E; Carbonell C; Castillo MJ; Chamorro AJ; Colunga D; Corbella X; Egurbide MV; Espinosa G; Fonollosa V; Freire M; García Hernández FJ; González León R; Guillén Del Castillo A; Iniesta N; Lorenzo R; Madroñero AB; Marí B; Marín A; Ortego-Centeno N; Pérez Conesa M; Pestaña M; Pla X; Ríos Blanco JJ; Rodríguez Carballeira M; Rubio Rivas M; Ruiz Muñoz M; Sáez Comet L; Segovia P; Simeón CP; Soto A; Tarí E; Todolí JA; Tolosa C; Trapiella L; Vargas Hitos JA; Verdejo G
    Clin Rheumatol; 2018 Apr; 37(4):999-1009. PubMed ID: 29214548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.
    Marí-Alfonso B; Simeón-Aznar CP; Guillén-Del Castillo A; Rubio-Rivas M; Trapiella-Martínez L; Todolí-Parra JA; Rodríguez Carballeira M; Marín-Ballvé A; Iniesta-Arandia N; Colunga-Argüelles D; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas Hitos JA; Chamorro AJ; Madroñero-Vuelta AB; Perales-Fraile I; Pla-Salas X; Fernández-De-La-Puebla RA; Fonollosa-Pla V; Tolosa-Vilella C; ;
    Semin Arthritis Rheum; 2018 Jun; 47(6):849-857. PubMed ID: 29246416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE).
    Rubio-Rivas M; Simeón-Aznar CP; Velasco C; Marí-Alfonso B; Espinosa G; Corbella X; Colunga-Argüelles D; Egurbide-Arberas MV; Ortego-Centeno N; Vargas-Hitos JA; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Fonollosa-Pla V;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):40-47. PubMed ID: 28229826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of early mortality in systemic sclerosis: a case-control study comparing early versus late mortality in systemic sclerosis.
    Derk CT; Huaman G; Littlejohn J; Otieno F; Jimenez S
    Rheumatol Int; 2012 Dec; 32(12):3841-4. PubMed ID: 22193226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].
    Rubio-Rivas M; Corbella X; Guillén-Del-Castillo A; Tolosa Vilella C; Colunga Argüelles D; Argibay A; Vargas Hitos JA; Todolí Parra JA; González-Echávarri C; Ortego-Centeno N; Trapiella Martínez L; Rodríguez Carballeira M; Marín Ballvé A; Pla Salas X; Perales Fraile I; Chamorro AJ; Madroñero Vuelta AB; Freire M; Ruiz Muñoz M; González García A; Pons Martín Del Campo I; Sánchez García ME; Bernal Bello D; Espinosa G; García Hernández FJ; Sáez Comet L; Ríos Blanco JJ; Fernández de la Puebla Giménez RÁ; Sánchez Trigo S; Fonollosa Pla V; Simeón Aznar CP; ;
    Autoimmun Rev; 2021 May; 20(5):102793. PubMed ID: 33766615
    [No Abstract]   [Full Text] [Related]  

  • 11. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry.
    Delisle VC; Hudson M; Baron M; Thombs BD; And The Canadian Scleroderma Research Group A
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-10-4. PubMed ID: 24144459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Campillo-Grau M; Ramos-Casals M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Caminal-Montero L; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban-Marcos EM; Pallarés-Ferreres L; Navarrete-Navarrete N; Vargas-Hitos JA; Torre RG; Salvador-Cervello G; Rios-Blanco JJ; Vilardell-Tarrés M;
    Medicine (Baltimore); 2015 Oct; 94(43):e1728. PubMed ID: 26512564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry.
    Shanmugam VK; Frech TM; Steen VD; Hummers LK; Shah AA; Bernstein EJ; Khanna D; Gordon JK; Castelino FV; Chung L; Hant FN; Startup E; VanBuren JM; Evnin LB; Assassi S
    Clin Rheumatol; 2020 Jan; 39(1):93-102. PubMed ID: 31667644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.
    Poormoghim H; Andalib E; Jalali A; Ghaderi A; Ghorbannia A; Mojtabavi N
    Rheumatol Int; 2016 Jul; 36(7):925-34. PubMed ID: 27061806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review.
    Freire M; Rivera A; Sopeña B; Tolosa Vilella C; Guillén-Del Castillo A; Colunga Argüelles D; Callejas Rubio JL; Rubio Rivas M; Trapiella Martínez L; Todolí Parra JA; Rodríguez Carballeira M; Iniesta Arandia N; García Hernández FJ; Egurbide Arberas MV; Sáez Comet L; Vargas Hitos JA; Ríos Blanco JJ; Marín Ballvé A; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Simeón Aznar CP;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):89-97. PubMed ID: 28980905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
    Ooi C; Solanki K; Lao C; Frampton C; White D
    Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
    Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
    Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.